(0)
0 Items £0.00

Take part in new research

Our research

Colposcopy: Healthcare Professional Information Needs Survey

A survey for UK-based colposcopists about whether there is enough information available for women who are referred.

Complete the survey here.

Other organisations

Opportunities to work with other organisations and researchers:

  • Gynae Cancer Patient Representatives Needed! The CR UK & UCL Cancer Trials Centre is looking for new Patient Representatives to join our Gynae Patient Representative Group. Our Patient Reps get involved through a  range of activities, such as reading over and commenting on trial patient information sheets, sitting on trial management group meetings or helping write trial result summaries for patients. For more information, contact contact Mandy Feeney at the the CR UK & UCL Cancer Trials Centre on 0207 679 9890 or [email protected]
  • University College London and Cancer Research UK (CRUK) are recruting participants for two clinical trials. The INTERLACE trial, for people whose stage 1B2 to 1Va cervical cancer cannot be removed by surgery, investigates whether an additional short-course of chemotherapy given on a weekly schedule immediately before standard chemoradiation is a better treatment. The SHAPE trial, for people with early stage 1A2 or 1B1 cervical cancer, compares whether a simple hysterectomy and removal of pelvic lymph nodes is as good a treatment as radical hysterectomy and removal of pelvic lymph nodes. Please discuss with your doctor if you are interested in taking part. More details are available on the CRUK website.
  • The Royal Marsden Hospital with the Institute of Cancer Research are conducting a trial looking at whether Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) is useful for the treatment of symptoms of women's cancers that have come back (e.g. pain, bleeding) in cases where other treatments (e.g. radiotherapy and chemotherapy) have not worked. Prof Nandita deSouza's team is recruiting eligible patients for the trial which is taking place at the Royal Marsden Hospital in Sutton, London. Please click here for more information or email the MRgHIFU Clinical Research Fellow Dr Georgios Imseeh ([email protected]) or call 020 8661 3119.

  • Are you 60-70 years old? Have you had an abnormal screening result in the last few years? Researchers at UCL want to explore attitudes to extending cervical screening post-64 years and are looking for women who are interested in helping design their research. If you are interested please contact Dr Laura Marlow by email: [email protected] or telephone 020 7679 1798
  • Clatterbridge Cancer Centre with the University of Liverpool are conducting a trial called COMICE looking at whether olaparib and cediranib can improve treatment for cancer of the cervix that has spread or come back. The trial will take place in participating hospitals around the UK and are planning to recruit eligible patients until November 2019. In this trial, some people have cediranib and olaparib and some have dummy drugs (placebo). Please click here for more information or email COMICE Trial Coordinator Karen Scott [email protected].

  • Help design a study to improve healthcare for women with gynaecological symptoms. This is a study for women aged 18 to 64 who have had any bleeding between periods or after sex in the past 2 years. Contact Alex Castanon on [email protected] to find out more.

  • The National Cancer Research Institute - Priority Setting Partnership: A survey asking questions about what people living with and beyond cancer feel are the most important questions for researchers to answer.

  • Share your experience of the NHS cervical screening programme: UCL are collecting your experiences to find out how the programme can offer more support.
Date last updated: 
11 Apr 2016

Have a question? Need to talk?

Our helpline is currently closed, find out when it’s next open.

Or submit your question via our Ask the Expert online service